Filing Details
- Accession Number:
- 0000878526-19-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-02 19:13:43
- Reporting Period:
- 2019-04-30
- Accepted Time:
- 2019-05-02 19:13:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
878526 | Natus Medical Inc | BABY | Electromedical & Electrotherapeutic Apparatus (3845) | 770154833 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247930 | A Robert Gunst | C/O Natus Medical Incorporated 6701 Koll Center Parkway, Suite 120 Pleasanton CA 94566 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Disposition | 2019-04-30 | 2,000 | $26.25 | 26,392 | No | 4 | S | Direct | |
Common Stock, $0.001 Par Value Per Share | Disposition | 2019-05-01 | 4,000 | $26.88 | 22,392 | No | 4 | S | Direct | |
Common Stock, $0.001 Par Value Per Share | Disposition | 2019-05-02 | 2,000 | $26.92 | 20,392 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $26.75 to $27.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $26.90 to $26.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.